FDA confirmed CMC and device plans are Phase 3 ready, coinciding with strengthening of US and EU patent estates.
2 reports, 2 independent
Updated Oct 22
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA confirmed CMC and device plans are Phase 3 ready, coinciding with strengthening of US and EU patent estates.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.EPO granted a drug patent while regulatory submissions were made to US and EU agencies.1 source
FDA confirmed Phase 3 readiness and US/EU patent estates are being strengthened.1 source
Keep exploring
The entities involved
- FDA
-
European Patent Office
one of the two organs of the European Patent Organisation
Nothing else this week.